Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,448 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Response and progression-free survival according to planned treatment duration in patients with relapsed multiple myeloma treated with carfilzomib, lenalidomide, and dexamethasone (KRd) versus lenalidomide and dexamethasone (Rd) in the phase III ASPIRE study.
Dimopoulos M, Wang M, Maisnar V, Minarik J, Bensinger W, Mateos MV, Obreja M, Blaedel J, Moreau P. Dimopoulos M, et al. J Hematol Oncol. 2018 Apr 4;11(1):49. doi: 10.1186/s13045-018-0583-7. J Hematol Oncol. 2018. PMID: 29615082 Free PMC article. Clinical Trial.
The treatment of multiple myeloma.
Alexanian R, Dimopoulos M. Alexanian R, et al. Among authors: dimopoulos m. N Engl J Med. 1994 Feb 17;330(7):484-9. doi: 10.1056/NEJM199402173300709. N Engl J Med. 1994. PMID: 8289856 Review. No abstract available.
VAD-cyclosporine therapy for VAD-resistant multiple myeloma.
Weber D, Dimopoulos M, Sinicrope F, Alexanian R. Weber D, et al. Among authors: dimopoulos m. Leuk Lymphoma. 1995 Sep;19(1-2):159-63. doi: 10.3109/10428199509059671. Leuk Lymphoma. 1995. PMID: 8574163 Clinical Trial.
Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue.
Giralt S, Weber D, Colome M, Dimopoulos M, Mehra R, Van Besien K, Gajewski J, Andersson B, Khouri I, Przepiorka D, von Wolff B, Delasalle K, Korbling M, Seong D, Alexanian R, Champlin R. Giralt S, et al. Among authors: dimopoulos m. J Clin Oncol. 1997 Feb;15(2):667-73. doi: 10.1200/JCO.1997.15.2.667. J Clin Oncol. 1997. PMID: 9053492 Clinical Trial.
Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myeloma.
Shimoni A, Smith TL, Aleman A, Weber D, Dimopoulos M, Anderlini P, Andersson B, Claxton D, Ueno NT, Khouri I, Donato M, Korbling M, Alexanian R, Champlin R, Giralt S. Shimoni A, et al. Among authors: dimopoulos m. Bone Marrow Transplant. 2001 Apr;27(8):821-8. doi: 10.1038/sj.bmt.1703007. Bone Marrow Transplant. 2001. PMID: 11477439 Clinical Trial.
1,448 results